S. 1492 · 111th Congress
Alzheimer's Breakthrough Act of 2009
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 111th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MikulskiSponsor45 cosponsors · 39 D, 4 R, 2 I
R
Bond
RB
R
Burr
SC
R
Collins
KG
D
Gillibrand
BM
D
Menendez
AF
D
Franken
BL
D
Lincoln
BS
I
Sanders
PL
D
Leahy
DS
D
Stabenow
JL
I
Lieberman
FL
D
Lautenberg
AK
D
Klobuchar
EK
D
Kaufman
PM
D
Murray
JR
D
Rockefeller
BB
D
Boxer
BC
D
Cardin
CD
D
Dodd
JT
D
Tester
SW
D
Whitehouse
MC
D
Cantwell
BC
D
Casey
CS
D
Schumer
TU
D
Udall
JK
D
Kerry
JR
D
Reed
MW
D
Warner
KH
D
Hagan
ML
D
Landrieu
TJ
D
Johnson
SB
D
Brown
RD
D
Durbin
JS
D
Shaheen
CM
D
McCaskill
TC
D
Carper
MB
D
Bennet
EB
D
Bayh
MB
D
Begich
RB
D
Byrd
RB
D
Burris
JM
D
Merkley
BD
D
Dorgan
HK
D
Kohl
CG
R
Grassley5 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Alzheimer's Breakthrough Act of 2009 - Authorizes appropriations for conducting and supporting research on Alzheimer's disease in FY2010-FY2014.
What it does: CRS summary · Introduced in Senate · Jul 22, 2009
Alzheimer's Breakthrough Act of 2009 - Authorizes appropriations for conducting and supporting research on Alzheimer's disease in FY2010-FY2014.
Amends the Public Health Service Act to require the Director of the National Institute on Aging to: (1) give priority to conducting and supporting Alzheimer's disease research; (2) increase the emphasis on the need to conduct Alzheimer's disease prevention trials within the National Institutes of Health (NIH); (3) ensure that Alzheimer's disease is maintained as a high priority for NIH's neuroscience initiative; and (4) conduct and support cooperative clinical research regarding Alzheimer's disease.
Requires the Director to conduct research related to: (1) the early detection, diagnosis, and prevention of Alzheimer's disease and its potential precursors; (2) early onset Alzheimer's disease and related dementias; (3) the relationship of vascular disease and Alzheimer's disease; and (4) interventions designed to help caregivers and improve patient outcomes.
Authorizes the Director to establish a National Alzheimer's Coordinating Center to facilitate collaborative research among the Alzheimer's Disease Centers and Alzheimer's Disease Research Centers.
Expands the research of Alzheimer's Disease Centers to include outcome measures and disease management.
Directs the Secretary of Health and Human Services (HHS) to convene a National Summit on Alzheimer's Disease.
Requires the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to conduct activities related to risk factors and early recognition of Alzheimer's disease and other dementias.
Requires the Secretary, acting through the Administration on Aging, to award a cooperative grant for the establishment and operation of an Alzheimer's Call Center.
Extends and expands demonstration projects relating to Alzheimer's disease.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Alzheimer's Breakthrough Act of 2009
Latest action (Jul 22, 2009): Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S7885-7887)
Policy area: Health · Origin: Senate · Introduced: Jul 22, 2009
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.